GLP-1 drugs are generally covered for diabetes, but insurance companies and employers have been more reluctant to do the same for weight loss - in large part because they are so popular and require long-term use often enough that total spending threatens to spiral out of control
Researchers have yet to establish a clear causal link between GLP-1 medications and these vision complications
GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2 diabetes, but their effectiveness as anti-obesity medications has generated tremendous excitement and high demand among people who have struggled to lose weight by other means
Semaglutide absorption was compared in a fed group that ate 30 min before dosing, a fasting group that did not eat until 4 h post dosing, and a reference group that ate 30 min post dosing
Heart disease is the leading cause of death in women
*Correspondence: Qiyuan Keith Liu, [email protected]
